Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CervoMed Inc.DFFN · Entity 7338 | Director · Chief Scientific Officer | January 02, 2020 | January 30, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CervoMed Inc.
Report date January 02, 2020 · Filed January 30, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.46 · Expires 2030-01-31 | Direct | 239,400 |
Reported balance
After 2020-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 239,400 · Balance 239,400 F1: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 30, 2020 21:55 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 239,400 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001437749-20-001423 · rdgdoc.xml · derivative · entry 1 Gainer John · CIK 0001662697 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,400 Underlying: Common Stock · 239,400 shares Expires 2030-01-31 F1 · derivative.exercise_date: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2020. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:02 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001437749-18-000260 · rdgdoc.xml · derivative · entry 1 Gainer John · CIK 0001662697 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2018. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:32 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001437749-17-008975 · rdgdoc.xml · derivative · entry 1 Gainer John · CIK 0001662697 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires 2027-05-10 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020. Read SEC document |
| May 10, 2017 Filed Jun 30, 2017 20:02 UTC Amendment | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001437749-17-012084 · rdgdoc.xml · derivative · entry 1 Gainer John · CIK 0001662697 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires 2027-05-10 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020. Read SEC document |
| December 08, 2016 Filed Dec 13, 2016 21:27 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001437749-16-043297 · rdgdoc.xml · derivative · entry 1 Gainer John · CIK 0001662697 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires 2026-12-08 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on November 30, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.